Myopia Day - Session 5 - Webinar: Beyond spectacles – real-world insights and three-year evidence in paediatric myopia control
When:
Time:
Where: Online
Interactive CPD points: 1
.png?rev=098c7e38a1914390904f87ed11464161&hash=1E66CAA477C5B3BE9DE538B38249798E){kind=logo}
Prices from: Free to members; non-members £25 inc. VAT Book or join now to attend this event
Optometry Today (OT), in partnership with the AOP and headline sponsor CooperVision, is pleased to present a full day of myopia-focused education.
This event features a series of online sessions delivered by national and international experts, offering valuable insights into the contemporary clinical management of myopia.
The programme includes six webinars, each providing one interactive CPD point. Attendees will have the opportunity to learn from leading experts in the field, build confidence in managing myopia and exchange knowledge with peers. Delegates may attend the full programme or choose individual sessions that best match their clinical interests.
Please note: You will not be eligible for CPD if you dial in to audio only using a phone.
Session 1: Spex, drugs or contact lenses – choosing the best intervention for controlling myopia in children - Book below
Session 2: Eyes on the future – what's new in myopia management - Book below
Session 3: 0.01% atropine for myopia control – from evidence to everyday practice - Book below
Session 4: How to identify and manage a pre-myope - Book below
Session 5: Beyond spectacles – real-world insights and three-year evidence in paediatric myopia control - Book now
Session 6: Make your impact – embracing orthokeratology in practice - Book below
Session 5: Beyond spectacles – real-world insights and three-year evidence in paediatric myopia control
Understanding the real-world challenges families face in managing childhood myopia is key to improving long term outcomes. This session explores insights from a survey capturing children’s and parents’ experiences with vision correction – highlighting the practical and social limitations of spectacles and the missed opportunity to discuss contact lenses early in the journey.
We will also review three year global clinical data demonstrating the sustained myopia control efficacy of a soft contact lens in children aged seven to 12 years. Attendees will gain evidence based insights to confidently broaden conversations with families and support informed, child appropriate vision correction choices.
Learning outcomes
- Practitioners will be able to communicate effectively with children and their families about myopia management (s.2)
- Practitioners will be able to apply evidence-based clinical knowledge to evaluate and recommend appropriate myopia management options for children (s.7).
2.30PM - 3.30PM
-
1 point
Webinar: Beyond spectacles – real-world insights and three-year evidence in paediatric myopia control
CPD ref no: C-115972
Interactive:
Practitioner type:
Domains:
Dr Alex Nixon
Dr Alex Nixon is a graduate of The Ohio State University (OSU) College of Optometry. He completed a fellowship in cornea and contact lenses at OSU, where he conducted research regarding scleral lenses and higher-order aberrations. He was a clinical assistant professor at OSU for several years, where he taught general clinical and contact lens practice and also conducted myopia control soft contact lens research for the BLINK Study Group.
He joined Johnson & Johnson Vision in 2019. His team's mission is to design and conduct rigorous research to identify evidence-based insights that shape the contact lens products of the future and define their benefits. He has led research related to myopia progression in children, contact lens clinical trials and translational vision science studies. Alex is also the clinical lead for the development of patient-reported outcomes questionnaires, which help quantify the clinical performance and benefits of our medical devices or treatments.
Dr Xu Cheng
Dr Xu Cheng is an ophthalmologist and vision scientist with over 30 years’ experience in clinical and vision science research. She earned her medical and master’s degrees in ophthalmology and vision science from Capital University of Medical Sciences and a PhD in vision science from Indiana University School of Optometry.
Since joining Johnson & Johnson Vision in 2003, Xu has led numerous contact lens clinical R&D initiatives focused on myopia control, visual optics and clinical methodologies. She has directed more than 100 clinical investigations and authored over 100 peer-reviewed publications, presentations and patents. As R&D myopia lead, she drives innovation and external collaborations and is a named inventor of Acuvue® Abiliti™ 1-Day lenses for myopia management.